FIRST TRACKS BIOTHERAPEUTICS - ANB033 PHASE 2 DEVELOPMENT IN VITILIGO AND ADDITIONAL INDICATION TO INITIATE IN H1 2027

Reuters · 2d ago

Please log in to view news